What's happening
This bill prohibits insurance plans and managed care programs in New York from requiring prior authorization or imposing delays for antiretroviral HIV/AIDS prescription drugs.
Why it matters
Reduces barriers to timely HIV/AIDS treatment and prevention. By eliminating prior authorization and step therapy for antiretroviral drugs, the bill seeks to ensure that people living with or at risk for HIV/AIDS can start or continue their medication without administrative delays, which is crucial for effective disease management and prevention.
Potentially improves public health outcomes. Easier, faster access to antiretroviral medications can help reduce HIV transmission rates and improve individual patient outcomes, supporting broader public health goals for HIV/AIDS control in New York.
Limits insurer and managed care plan discretion. The bill restricts insurance companies and managed care providers from using cost-containment protocols that could delay or limit access to these specific drugs, shifting the focus toward patient care over administrative or cost-saving considerations.
Standardizes coverage across insurance types. By amending public health, social services, and insurance laws, the bill ensures that these protections apply broadly—across public health plans, Medicaid managed care, and private insurance—reducing disparities in access to lifesaving medication.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Protect HIV Drug Access
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Referred to insurance
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
No Delays for HIV Drugs
In Senate Committee · Health · Sponsor Brad Hoylman-Sigal
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
9580
IN ASSEMBLY
March 16, 2022
Introduced by M. of A. L. ROSENTHAL -- read once and referred to the Committee on Insurance
AN ACT to amend the public health law, in relation to prohibiting the preferred drug program from restricting or imposing delays in the distribution of antiretroviral prescription drugs to certain persons; to amend the social services law, in relation to prohibiting managed care programs from restricting or imposing delays in the distribution of antiretroviral prescription drugs to certain persons; and to amend the insurance law, in relation to prohibiting insurers from restricting or imposing delays in the distribution of antiretroviral prescription drugs to certain persons
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Section 273 of the public health law is amended by adding a new subdivision 11 to read as follows:
11. No prior authorization, step therapy, or any other protocol that could restrict or delay the dispensing of the drug shall be required for antiretroviral prescription drugs prescribed to a person in a state public health plan for the treatment or prevention of the human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS).
§ 2. Section 364-j of the social services law is amended by adding a new subdivision 26-d to read as follows:
26-d. Managed care providers shall not subject an antiretroviral prescription drug prescribed to a person for the treatment or prevention of the human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) to a prior authorization requirement, step therapy, or any other protocol that could restrict or delay the dispensing of the drug.
§ 3. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 36 to read as follows:
(36) No policy that provides coverage for antiretroviral prescription drugs prescribed for the treatment or prevention of the human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) shall subject such drugs to prior authorization requirement, step therapy, or
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD14725-01-2
any other protocol that could restrict or delay the dispensing of the drug.
§ 4. Subsection (l) of section 3221 of the insurance law is amended by adding a new paragraph 21 to read as follows:
(21) Every group or blanket policy delivered or issued for delivery in this state that provides coverage for antiretroviral prescription drugs for the treatment or prevention of the human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) shall not subject such drug to a prior authorization requirement, step therapy, or any other protocol that could restrict or delay the dispensing of the drug.
§ 5. Section 4303 of the insurance law is amended by adding a new subsection (ss) to read as follows:
(ss) Any contract issued by a medical expense indemnity corporation, a hospital service corporation or a health services corporation that provides coverage for antiretroviral prescription drugs for the treatment or prevention of the human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) shall not subject such drug to a prior authorization requirement, step therapy, or any other protocol that could restrict or delay the dispensing of the drug.
§ 6. This act shall take effect on the first of January next succeeding the date on which it shall have become a law; provided, however, that sections three, four and five of this act shall apply to all coverage, contracts or policies issued, reissued, renewed, modified, altered or amended on or after such effective date; and provided further, however, that the amendments to section 364-j of the social services law made by section two of this act, shall not affect the repeal of such section and shall be deemed repealed therewith. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.